GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET IS EXPECTED TO GROW AT A CAGR OF 6.6% DURING THE FORECAST PERIOD

Mourya
Mourya
The report "ACTIVE PHARMACEUTICAL INGREDIENT MARKET": By Business Mode (Merchant Active Pharmaceutical Ingredients, Captive Active Pharmaceutical Ingredients); By Type Of Synthesis (Biotech, Synthetic); By Customer Base (Branded, Generic); By Application (Orthopedics, Neurology, Ophthalmology, Oncology, Pulmonology, Cardiology); & By Geography - Forecast (2018-2024). Envision intelligence estimates that the Global Active Pharmaceutical Ingredient Market Size is projected to reach $ 238.7Billion by the end of 2024 with a CAGR of 6.6%. Download a free sample active pharmaceutical ingredient market report pdf at https://www.envisioninteligence.com/industry-report/active-pharmaceutical-ingredient-market/ Active Pharmaceutical Ingredients (API) are the active substances that are used in the manufacture of a drug and they provide health benefits. It is the organ by which active pharmaceutical ingredients are manufactured from raw materials through chemical and physical means. Increasing incidence of chronic diseases, technological advancements in manufacturing of API, rising prevalence of cancer, increasing uptake of biopharmaceuticals are the major active pharmaceutical ingredient market trends boosting the growth of the market. As per Active Pharmaceutical Ingredient market report, Synthetic Segment holds the largest market share Synthetic segment reckons for largest market share due to the rising demand for protein-based therapeutics, increasing the focus of key traditional manufacturers toward biological drugs. Based on Business mode, merchant active pharmaceutical ingredient is witnessed to be the fastest growing segment. Captive active pharmaceutical ingredient segment holds the highest Active pharmaceutical ingredient market share and merchant active pharmaceutical ingredient is expected to be the fastest growing segment during the forecast period 2018-2024. Based on the Customer base, Generics segment is witnessed to be the fastest growing segment during the forecast period 2018-2024. The branded segment has dominated the market in 2016 due to high prescription rate, extensive drug development initiatives, and high price. The generic segment is expected to be the fastest growing segment during the forecast period 2018-2024. Due to the patient expiration of branded drugs, the companies are facing tremendous losses and they are preferring generic drugs over the branded ones. Based on Application, Oncology is witnessed to be the fastest growing segment during the forecast period 2018-2024. Cardiology segment has dominated the market in 2016 due to the higher prevalence rate and high amount of product availability. Oncology is witnessed to be the fastest growing segment due to rising number of clinical trials targeting cancer biomarkers for lung, prostate cancers, and breast, reduction in the cost of drug discovery for companion diagnostic test in oncology. Oncology is witnessed to have highest CAGR of 8% during the forecast period. According to the Active pharmaceutical ingredient report, North America holds the largest share of global API market size and is expected to grow at a high rate during the forecast period 2018-2024 due to the increasing R & D expenditure, rising favorable government initiatives for usage of generic drugs and technological advancements in the field of drug manufacturing. Europe is one of the dominant regions. In Europe, Germany and France are the largest revenue contributors in this region due to European government policy strongly supports the consumption of generic drugs over the branded drug. Asia-Pacific is witnessed to be the fastest growing region during the forecast period due to the availability of affordable labor. Active Pharmaceutical Ingredient Market in India is witnessed to grow at an API Market share of 6.3%. South America is expected to have the growth due to rapidly expanding economies and improving healthcare sector. In South America, Brazil is witnessed to have the stunning growth due to the increasing aging population and strengthening healthcare systems. Middle East & Africa is expected to have the moderate growth due to increasing prevalence of various infections and developing pharmaceutical industry in the region. “Active Pharmaceutical Ingredient Trends” Dr. Reddy’s Laboratories announces the launch of their new product Melphalan Hydrochloride for Injection in the U.S. Market. Major players in the market: Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Glaxosmithkline PLC Novartis International AG Sanofi